From Bench to Bedside—Driving cell and gene therapy development from candidate identification through commercialization
Whether you need to improve non-clinical or clinical development pathways, optimize manufacturing, improve delivery, or reduce time spent on regenerative medicine assets, your goal is accelerate the path to market. We partner to help you solve the unique challenges faced in the development and commercialization of cell and gene therapies.
With the IQVIA Stem Cell Center, you get the support you need to achieve regenerative medicine and cell and gene therapy goals, regardless of your organization’s size, the development stage of your assets, or the source of funding. We leverage our long track record of success and hands-on experience, proprietary data, and analytics to help you accelerate development from candidate identification, through marketing authorization.
Our capabilities drive value for you in four areas:
- End-to-end and customized solutions: Integrated services that provide a one stop shop and optimize efficiency throughout asset development
- Strategic advice to operation delivery: Strategic planning, backed by deep industry expertise, to improve the probability of clinical and commercial success
- Best and next practices: Cross-functional teams that leverage scientific, clinical, regulatory, and commercial experience
- Coordinated, partnered delivery: Partnerships with premier organizations to deliver seamless program management across the product development lifecycle
We can also help you optimize the development of your CIRM (California Institute for Regenerative Medicine) application for translational and clinical grants.
Our core offerings